
Morgan Stanley has invested 0% in AtriCure, Inc. (NASDAQ:ATRC).
Jan 1, 2018 | flecha123.comThe Illinois-based fund Oberweis Asset Management Inc have invested about 1.54% of the institutional investor’s stock portfolio in Atricure Inc.
Jan 1, 2018 | enbulletin.comAtriCure acquired Enable Medical in 2005.
Jan 1, 2021 | prnewswire.comAtriCure (Nasdaq: ATRC), a Mason-based medical device maker known largely for its surgical treatments and therapies for atrial fibrillation, appointed Deborah Yount as its chief human resources officer, effective June 1.
Jan 1, 2022 | bizjournals.comAtriCure has been named to Top Workplaces lists multiple times over the past decade.
Dec 8, 2022 | benzinga.comAtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has launched the EnCompass Clamp ®, a part of the Isolator Synergy™ Ablation System in the United States.
Apr 11, 2022 | atricure.com